EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation tests

Chiara Angela Bizzozero iD, Sophie Monnerat iD, Fiona A Chapman iD, Neeraj Dhaun iD, Julie Refardt iD, Mirjam Christ-Crain iD

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae138 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Chiara Angela Bizzozero und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Glycopeptides, Apelin, Polyuria, Arginine Vasopressin. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Differentiating between arginine vasopressin deficiency (AVP-D) and primary polydipsia (PP) requires a copeptin stimulation test. We aimed to characterize changes in apelin, an endogenous hormone antagonizing AVP, upon copeptin stimulation tests.

Design

Post hoc secondary analysis of a multi-centric cross-over diagnostic study (NCT03572166).

Setting

Outpatients included at the University Hospital Basel.

Participants

Patients with AVP-D and PP.

Interventions

Copeptin stimulation tests with hypertonic saline and arginine infusion. Outcomes and Measures The primary outcome was the absolute difference in apelin between baseline and peak of copeptin stimulation tests. Secondary objectives included the diagnostic ability of apelin.

Results

Thirty-eight patients were analysed, 23 (60%) had PP and 15 (40%) had AVP-D. No difference was seen between baseline median (IQR) apelin levels in PP and AVP-D (1079 [912, 1225] and 910 [756, 1039] pmol/L, respectively). Upon hypertonic saline, apelin decreased by −241 (−326, −124) pmol/L in PP and −47.2 (−198, 5.86) pmol/L in AVP-D (P = .022). The area under the curve (AUC) to differentiate PP from AVP-D was 97.1% (95% CI, 90.5-100) for copeptin and 49.3% (95% CI, 30.4-68.1) for apelin (P < .001). Upon arginine, apelin decreased by −39.2 (−96.4, 39.8) pmol/L in PP and increased by 25.8 (2.8, 113.0) pmol/L in AVP-D (P = .1). The AUC was 97.1% (95% CI: 79.6-98.0) for copeptin and 60.5% (95% CI: 39.8-80.0) for apelin (P = .007). Conclusions and Relevance Our findings suggest that apelin decreases to a greater extent in PP compared with AVP-D upon copeptin stimulation tests. However, copeptin remains the best marker to differentiate AVP-D from PP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycopeptidesApelinPolyuriaArginine VasopressinHumansMaleFemaleAdultMiddle AgedPolydipsiaArginineCross-Over StudiesSaline Solution, HypertonicYoung Adult

Stichwörter der Autor:innen

AVP deficiencyapelincopeptindiabetes insipidusprimary polydipsia

Substanzen

GlycopeptidescopeptinsApelinArginine VasopressinArginineSaline Solution, HypertonicAPLN protein, human

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland.
  • Department of Clinical Research, University of Basel, Basel, Switzerland.
  • BHF/University Centre for Cardiovascular Science, The Queen's Medical Research Institute, Edinburgh, United Kingdom.
  • Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.

ORCID-Profile: Chiara Angela Bizzozero, Sophie Monnerat, Fiona A Chapman, Neeraj Dhaun, Julie Refardt, Mirjam Christ-Crain

Förderung

  • Swiss National Science Foundation

Zitieren

APA

Bizzozero, C. A., Monnerat, S., Chapman, F. A., Dhaun, N., Refardt, J., & Christ-Crain, M. (2024). Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation tests. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae138

Vancouver

Bizzozero CA, Monnerat S, Chapman FA, Dhaun N, Refardt J, Christ-Crain M. Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation tests. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae138

BibTeX
@article{Bizzozero2024,
  author = {Bizzozero, Chiara Angela and Monnerat, Sophie and Chapman, Fiona A and Dhaun, Neeraj and Refardt, Julie and Christ-Crain, Mirjam},
  title = {Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation tests},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae138}
}
Kostenlos starten →